Base de dados : MEDLINE
Pesquisa : C10.597.606.358.800.600 [Categoria DeCS]
Referências encontradas : 9638 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 964 ir para página                         

  1 / 9638 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28455405
[Au] Autor:Li Kam Wa ME; Taraborrelli P; Hayat S; Lim PB
[Ad] Endereço:Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.
[Ti] Título:Respiration driven excessive sinus tachycardia treated with clonidine.
[So] Source:BMJ Case Rep;2017, 2017 Apr 28.
[Is] ISSN:1757-790X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:A 26-year-old man presented to our syncope service with debilitating daily palpitations, shortness of breath, presyncope and syncope following a severe viral respiratory illness 4 years previously. Mobitz type II block had previously been identified, leading to a permanent pacemaker and no further episodes of frank syncope. Transthoracic echocardiography, electophysiological study and repeated urine metanepherines were normal. His palpitations and presyncope were reproducible on deep inspiration, coughing, isometric hand exercise and passive leg raises. We demonstrated rapid increases in heart rate with no change in morphology on his 12 lead ECG. His symptoms were resistant to fludrocortisone, flecainide, ß blockers and ivabradine. Initiation of clonidine in combination with ivabradine led to rapid resolution of his symptoms. We suggest that an excessive respiratory sinus arrhythmia was responsible for his symptoms and achieved an excellent response with the centrally acting sympatholytic clonidine, where previous peripherally acting treatments had failed.
[Mh] Termos MeSH primário: Inalação/fisiologia
Síncope/fisiopatologia
Taquicardia Sinusal/complicações
[Mh] Termos MeSH secundário: Agonistas de Receptores Adrenérgicos alfa 2/administração & dosagem
Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico
Adulto
Benzazepinas/administração & dosagem
Benzazepinas/uso terapêutico
Fármacos Cardiovasculares/administração & dosagem
Fármacos Cardiovasculares/uso terapêutico
Clonidina/administração & dosagem
Clonidina/uso terapêutico
Tosse/complicações
Tosse/etiologia
Quimioterapia Combinada/métodos
Dispneia/diagnóstico
Dispneia/etiologia
Ecocardiografia/métodos
Eletrocardiografia/métodos
Seres Humanos
Masculino
Síncope/etiologia
Taquicardia/etiologia
Taquicardia/fisiopatologia
Taquicardia Sinusal/diagnóstico por imagem
Taquicardia Sinusal/tratamento farmacológico
Taquicardia Sinusal/fisiopatologia
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Adrenergic alpha-2 Receptor Agonists); 0 (Benzazepines); 0 (Cardiovascular Agents); 3H48L0LPZQ (ivabradine); MN3L5RMN02 (Clonidine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180220
[Lr] Data última revisão:
180220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170430
[St] Status:MEDLINE


  2 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29301428
[Au] Autor:Barkil-Oteo A; Abdallah W; Mourra S; Jefee-Bahloul H
[Ad] Endereço:From the Department of Psychiatry, Yale University, New Haven, Conn.; the Department of Psychiatry, Howard University Hospital, Washington, DC; the Department of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles; and the Department of Psychiatry, UMass Medical School, Worcester, Mass.
[Ti] Título:Trauma and Resiliency: A Tale of a Syrian Refugee.
[So] Source:Am J Psychiatry;175(1):8-12, 2018 Jan 01.
[Is] ISSN:1535-7228
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Ansiedade
Depressão
Exposição à Violência/psicologia
Psicoterapia/métodos
Refugiados/psicologia
Inibidores da Captação de Serotonina/administração & dosagem
Transtornos de Estresse Pós-Traumáticos
Síncope
[Mh] Termos MeSH secundário: Adulto
Ansiedade/diagnóstico
Ansiedade/terapia
Depressão/diagnóstico
Depressão/psicologia
Feminino
Seres Humanos
Sintomas Inexplicáveis
Dor/etiologia
Dor/psicologia
Processos Psicoterapêuticos
Campos de Refugiados
Resiliência Psicológica
Autogestão/métodos
Apoio Social
Transtornos de Estresse Pós-Traumáticos/complicações
Transtornos de Estresse Pós-Traumáticos/diagnóstico
Transtornos de Estresse Pós-Traumáticos/psicologia
Síncope/etiologia
Síncope/psicologia
Síria
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Serotonin Uptake Inhibitors)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180106
[St] Status:MEDLINE
[do] DOI:10.1176/appi.ajp.2017.17030358


  3 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29245221
[Au] Autor:Duckheim M; Klee K; Götz N; Helle P; Groga-Bada P; Mizera L; Gawaz M; Zuern CS; Eick C
[Ad] Endereço:aDepartment of Cardiology, Innere Medizin III, Eberhard-Karls-Universität Tübingen, TübingenbDepartment of Internal Medicine, Filderklinik Stuttgart, Stuttgart, Germany.
[Ti] Título:Deceleration capacity as a risk predictor in patients presenting to the emergency department with syncope: A prospective exploratory pilot study.
[So] Source:Medicine (Baltimore);96(49):e8605, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Syncope is a common cause for admission to the emergency department (ED). Due to limited clinical resources there is great interest in developing risk stratification tools that allow identifying patients with syncope who are at low risk and can be safely discharged. Deceleration capacity (DC) is a strong risk predictor in postinfarction and heart failure patients. The aim of this study was to evaluate whether DC provides prognostic information in patients presenting to ED with syncope.We prospectively enrolled 395 patients presenting to the ED due to syncope. Patient's electrocardiogram (ECG) for the calculation of DC was recorded by monitoring devices which were started after admission. Both the modified early warning score (MEWS) and the San Francisco syncope score (SFSS) were determined in every patient. Primary endpoint was mortality after 180 days.Eight patients (2%) died after 180 days. DC was significantly lower in the group of nonsurvivors as compared with survivors (3.1 ±â€Š2.5 ms vs 6.7 ±â€Š2.4 ms; P < .001), whereas the MEWS was comparable in both was comparable in both groups. (2.1 ±â€Š0.8 vs 2.1 ±â€Š1.0; P = .84). The SFSS failed at identifying 4 of 8 nonsurvivors (50%) as high risk patients. No patient with a favorable DC (≥7 ms) died (0.0% vs 3.7%; P = .01, OR 0.55 (95% CI 0.40-0.76), P < .001). In the receiver operating characteristic (ROC) analysis DC yielded an area under the curve of 0.85 (95% CI 0.71-0.98).Our study demonstrates that DC is a predictor of 180-days-mortality in patients admitted to the ED due to syncope. Syncope patients at low risk can be identified by DC and may be discharged safely.
[Mh] Termos MeSH primário: Eletrocardiografia/métodos
Frequência Cardíaca/fisiologia
Medição de Risco/métodos
Síncope/fisiopatologia
[Mh] Termos MeSH secundário: Adulto
Idoso
Área Sob a Curva
Sistema Nervoso Autônomo/fisiologia
Causas de Morte
Serviço Hospitalar de Emergência
Feminino
Hospitalização
Seres Humanos
Masculino
Meia-Idade
Alta do Paciente
Projetos Piloto
Valor Preditivo dos Testes
Prognóstico
Estudos Prospectivos
Curva ROC
Taxa Respiratória/fisiologia
Síncope/mortalidade
[Pt] Tipo de publicação:EVALUATION STUDIES; JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171222
[Lr] Data última revisão:
171222
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171217
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000008605


  4 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28457108
[Au] Autor:Goldenberg G; Bental T; Kadmon U; Zabarsky R; Kusnick J; Barsheshet A; Golovchiner G; Strasberg B
[Ad] Endereço:Department of Cardiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
[Ti] Título:Syncope in Primary Prevention Implantable Cardioverter Defibrillator Implantation.
[So] Source:Isr Med Assoc J;19(1):15-18, 2017 Jan.
[Is] ISSN:1565-1088
[Cp] País de publicação:Israel
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Syncope prognosis varies widely: 1 year mortality may range from 0% in the case of vasovagal events up to 30% in the presence of heart disease. OBJECTIVES: To assess the outcomes and prognosis of patients with implantable cardiac defibrillator (ICD) and indication of primary prevention and compare patients presenting with or without prior syncope. METHODS: We reviewed the charts of 75 patients who underwent ICD implantation with the indication of primary prevention and history of syncope and compared them to a control group of 80 patients without prior syncope. We assessed the number of ventricular tachycardia (VT), ventricular fibrillation (VF), shock, anti-tachycardia pacing (ATP), and death in each group during the follow-up. RESULTS: Mean follow-up was 893 days (810-976, 95% confidence interval) (no difference between groups). Patients with prior syncope had a higher ejection fraction (EF) (35.5 ± 12.6 vs. 31.4 ± 8.76, P = 0.02), more episodes of VT (21.3% vs. 3.8%, P = 0.001) and VF (8% vs. 0%, P = 0.01) and also received more electric shocks (18.7% vs. 3.8%, P = 0.004) and ATP (17.3% vs. 6.2%, P = 0.031). There were no differences in inappropriate shocks (6.7% vs. 5%, P = 0.74), in cardiovascular mortality (cumulative 5 year estimate 29.9% vs. 32.2% P = 0.97) and any death (cumulative 5 year estimate 38.1% vs. 48.9% P = 0.18) during the follow-up. CONCLUSIONS: Syncopal patients before ICD implantation seem to have more episodes of VT/VF and shock or ATP. No mortality differences were observed.
[Mh] Termos MeSH primário: Morte Súbita Cardíaca/prevenção & controle
Desfibriladores Implantáveis
Prevenção Primária
Síncope/prevenção & controle
[Mh] Termos MeSH secundário: Idoso
Estudos de Casos e Controles
Feminino
Seres Humanos
Masculino
Estudos Retrospectivos
Volume Sistólico
Síncope/complicações
Taquicardia Ventricular/complicações
Fibrilação Ventricular/complicações
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170501
[St] Status:MEDLINE


  5 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29061871
[Au] Autor:Kemper AR; Barnett ED; Walter EB; Hornik C; Pierre-Joseph N; Broder KR; Silverstein M; Harrington T
[Ad] Endereço:Division of Ambulatory Pediatrics, Nationwide Children's Hospital, Columbus, Ohio; alex.kemper@nationwidechildrens.org.
[Ti] Título:Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial.
[So] Source:Pediatrics;140(5), 2017 Nov.
[Is] ISSN:1098-4275
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND AND OBJECTIVES: Postvaccination syncope can cause injury. Drinking water prephlebotomy increases peripheral vascular tone, decreasing risk of blood-donation presyncope and syncope. This study evaluated whether drinking water prevaccination reduces postvaccination presyncope, a potential syncope precursor. METHODS: We conducted a randomized trial of subjects aged 11 to 21 years receiving ≥1 intramuscular vaccine in primary care clinics. Intervention subjects were encouraged to drink 500 mL of water, with vaccination recommended 10 to 60 minutes later. Control subjects received usual care. Presyncope symptoms were assessed with a 12-item survey during the 20-minutes postvaccination. Symptoms were classified with a primary cutoff sensitive for presyncope, and a secondary, more restrictive cutoff requiring greater symptoms. Results were adjusted for clustering by recruitment center. RESULTS: There were 906 subjects randomly assigned to the control group and 901 subjects randomly assigned to the intervention group. None had syncope. Presyncope occurred in 36.2% of subjects by using the primary definition, and in 8.0% of subjects by using the restrictive definition. There were no significant differences in presyncope by intervention group for the primary (1-sided test, = .24) or restrictive outcome (1-sided test, = .17). Among intervention subjects vaccinated within 10 to 60 minutes after drinking all 500 mL of water ( = 519), no reduction in presyncope was observed for the primary or restrictive outcome (1-sided tests, = .13, = .17). In multivariable regression analysis, presyncope was associated with younger age, history of passing out or nearly passing out after a shot or blood draw, prevaccination anxiety, receiving >1 injected vaccine, and greater postvaccination pain. CONCLUSIONS: Drinking water before vaccination did not prevent postvaccination presyncope. Predictors of postvaccination presyncope suggest opportunities for presyncope and syncope prevention interventions.
[Mh] Termos MeSH primário: Água Potável/administração & dosagem
Ingestão de Líquidos/fisiologia
Síncope/etiologia
Síncope/prevenção & controle
Vacinação/efeitos adversos
[Mh] Termos MeSH secundário: Adolescente
Criança
Feminino
Seres Humanos
Masculino
Síncope/fisiopatologia
Vacinação/tendências
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Drinking Water)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171025
[St] Status:MEDLINE


  6 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29020587
[Au] Autor:Pasquier M; Clair M; Pruvot E; Hugli O; Carron PN
[Ad] Endereço:From Lausanne University Hospital, Lausanne, Switzerland.
[Ti] Título:Carotid Sinus Massage.
[So] Source:N Engl J Med;377(15):e21, 2017 Oct 12.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Seio Carotídeo/fisiopatologia
Massagem
Síncope/etiologia
[Mh] Termos MeSH secundário: Tontura/etiologia
Seres Humanos
Taquicardia Supraventricular/diagnóstico
Taquicardia Supraventricular/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW; VIDEO-AUDIO MEDIA
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171019
[Lr] Data última revisão:
171019
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171012
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMvcm1313338


  7 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28966307
[Au] Autor:Yagi S; Soeki T; Aihara KI; Fukuda D; Ise T; Kadota M; Bando S; Matsuura T; Tobiume T; Yamaguchi K; Kusunose K; Yamada H; Wakatsuki T; Shimabukuro M; Akaike M; Sata M
[Ad] Endereço:Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
[Ti] Título:Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome.
[So] Source:Int Heart J;58(5):720-723, 2017 Oct 21.
[Is] ISSN:1349-3299
[Cp] País de publicação:Japan
[La] Idioma:eng
[Ab] Resumo:The n-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have antiarrhythmic effects, possibly via modulation of the cardiac ion channels. Nevertheless, it is unknown whether low serum levels of n-3 PUFAs are risk factors for ventricular fibrillation in patients with Brugada syndrome (BrS). We retrospectively reviewed data from 62 men with BrS and evaluated their serum levels of EPA and DHA, and the risk factors for sudden cardiac death, including a history of cardiogenic syncope. Nineteen patients had a history of cardiogenic syncope, and their EPA and DHA levels were significantly lower than those of the patients without syncope. Multivariate logistic regression analysis revealed that low EPA and DHA levels were associated with the incidence of syncope. The receiver-operator characteristic curve showed the area under the curves of EPA and DHA for history of syncope were 0.84 and 0.72, respectively. In conclusion, low levels of EPA and DHA are risk factors for cardiogenic syncope in patients with BrS, which suggests that n-3 PUFAs play important roles in preventing ventricular fibrillation in BrS.
[Mh] Termos MeSH primário: Síndrome de Brugada/complicações
Ácidos Docosa-Hexaenoicos/sangue
Ácido Eicosapentaenoico/sangue
Medição de Risco/métodos
Síncope/sangue
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Biomarcadores/sangue
Síndrome de Brugada/sangue
Síndrome de Brugada/fisiopatologia
Cromatografia Gasosa
Eletrocardiografia
Seguimentos
Seres Humanos
Incidência
Japão/epidemiologia
Masculino
Meia-Idade
Prevalência
Curva ROC
Estudos Retrospectivos
Fatores de Risco
Síncope/epidemiologia
Síncope/etiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY
[Nm] Nome de substância:
0 (Biomarkers); 25167-62-8 (Docosahexaenoic Acids); AAN7QOV9EA (Eicosapentaenoic Acid)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171102
[Lr] Data última revisão:
171102
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171003
[St] Status:MEDLINE
[do] DOI:10.1536/ihj.16-278


  8 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28738139
[Au] Autor:Juraschek SP; Daya N; Rawlings AM; Appel LJ; Miller ER; Windham BG; Griswold ME; Heiss G; Selvin E
[Ad] Endereço:Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland.
[Ti] Título:Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.
[So] Source:JAMA Intern Med;177(9):1316-1323, 2017 Sep 01.
[Is] ISSN:2168-6114
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Importance: Guidelines recommend assessing orthostatic hypotension (OH) 3 minutes after rising from supine to standing positions. It is not known whether measurements performed immediately after standing predict adverse events as strongly as measurements performed closer to 3 minutes. Objective: To compare early vs later OH measurements and their association with history of dizziness and longitudinal adverse outcomes. Design, Setting, and Participants: This was a prospective cohort study of middle-aged (range, 44-66 years) participants in the Atherosclerosis Risk in Communities Study (1987-1989). Exposures: Orthostatic hypotension, defined as a drop in blood pressure (BP) (systolic BP ≥20 mm Hg or diastolic BP ≥10 mm Hg) from the supine to standing position, was measured up to 5 times at 25-second intervals. Main Outcomes and Measures: We determined the association of each of the 5 OH measurements with history of dizziness on standing (logistic regression) and risk of fall, fracture, syncope, motor vehicle crashes, and all-cause mortality (Cox regression) over a median of 23 years of follow-up (through December 31, 2013). Results: In 11 429 participants (mean age, 54 years; 6220 [54%] were women; 2934 [26%] were black) with at least 4 OH measurements after standing, after adjustment OH assessed at measurement 1 (mean [SD], 28 [5.4] seconds; range, 21-62 seconds) was the only measurement associated with higher odds of dizziness (odds ratio [OR], 1.49; 95% CI, 1.18-1.89). Measurement 1 was associated with the highest rates of fracture, syncope, and death at 18.9, 17.0, and 31.4 per 1000 person-years. Measurement 2 was associated with the highest rate of falls and motor vehicle crashes at 13.2 and 2.5 per 1000 person-years. Furthermore, after adjustment measurement 1 was significantly associated with risk of fall (hazard ratio [HR], 1.22; 95% CI, 1.03-1.44), fracture (HR, 1.16; 95% CI, 1.01-1.34), syncope (HR, 1.40; 95% CI, 1.20-1.63), and mortality (HR, 1.36; 95% CI, 1.23-1.51). Measurement 2 (mean [SD], 53 [7.5] seconds; range, 43-83 seconds) was associated with all long-term outcomes, including motor vehicle crashes (HR, 1.43; 95% CI, 1.04-1.96). Measurements obtained after 1 minute were not associated with dizziness and were inconsistently associated with individual long-term outcomes. Conclusions and Relevance: In contrast with prevailing recommendations, OH measurements performed within 1 minute of standing were the most strongly related to dizziness and individual adverse outcomes, suggesting that OH be assessed within 1 minute of standing.
[Mh] Termos MeSH primário: Acidentes por Quedas
Determinação da Pressão Arterial/métodos
Tontura
Fraturas Ósseas
Hipotensão Ortostática
Síncope
[Mh] Termos MeSH secundário: Acidentes por Quedas/prevenção & controle
Acidentes por Quedas/estatística & dados numéricos
Pressão Sanguínea/fisiologia
Tontura/etiologia
Tontura/fisiopatologia
Feminino
Fraturas Ósseas/epidemiologia
Fraturas Ósseas/etiologia
Fraturas Ósseas/prevenção & controle
Seres Humanos
Hipotensão Ortostática/complicações
Hipotensão Ortostática/diagnóstico
Hipotensão Ortostática/mortalidade
Hipotensão Ortostática/fisiopatologia
Masculino
Meia-Idade
Mortalidade
Medição de Risco/métodos
Síncope/epidemiologia
Síncope/etiologia
Síncope/prevenção & controle
Fatores de Tempo
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:171101
[Lr] Data última revisão:
171101
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170725
[St] Status:MEDLINE
[do] DOI:10.1001/jamainternmed.2017.2937


  9 / 9638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28732008
[Au] Autor:Bhangu J; King-Kallimanis BL; Donoghue OA; Carroll L; Kenny RA
[Ad] Endereço:The Irish Longitudinal Study on Ageing, Trinity College, Dublin, Ireland.
[Ti] Título:Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment.
[So] Source:PLoS One;12(7):e0180997, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: To calculate the prevalence of all falls, non-accidental falls and syncope in an older population and characterize cardiovascular risk profiles. DESIGN: Prospective, longitudinal cohort study. SETTING: The first two waves of data from the Irish Longitudinal Study on Ageing (TILDA). PARTICIPANTS: 8172 community-dwelling adults aged 50 years and older resident in the Republic of Ireland. MEASUREMENTS: Self-reported history of all falls, non-accidental falls and syncope in the year preceding the first two waves of data collection. Demographic factors and self-reported cardiovascular conditions were used to characterize cardiovascular risk profiles. RESULTS: The prevalence of all falls in the past year was 19.2% or 192 per thousand persons and increased with age (50-64 years 17.5%; 65-74 years 19.4%; 75+ years 24.4%). Non-accidental falls had an estimated prevalence of 5.1% or 51 falls per thousand persons and accounted for 26.5% of all falls reported and also increased with age (50-64 years 4.0%; 65-74 years 5.5%; 75+ years 8.0%). The prevalence for syncope was estimated to be 4.4% or 44per thousand persons but did not show a similar age gradient. Participants with at least 5 cardiovascular conditions were more likely to report all falls (OR = 2.07, 95% CI 1.18-3.64, p<0.05) and NAF (OR = 2.89, 95%CI 1.28-6.52, p<0.05). CONCLUSIONS: The prevalence of all falls and non-accidental falls increases with age but the same pattern was not consistently observed for syncope. There is an increased odds of reporting all three outcomes with increasing number of self-reported cardiovascular conditions. Further work is needed to uncover the interplay between cardiovascular disease and subsequent falls.
[Mh] Termos MeSH primário: Acidentes por Quedas
Síncope/epidemiologia
[Mh] Termos MeSH secundário: Acidentes por Quedas/estatística & dados numéricos
Fatores Etários
Idoso
Doenças Cardiovasculares/epidemiologia
Feminino
Seres Humanos
Incidência
Irlanda/epidemiologia
Estudos Longitudinais
Masculino
Meia-Idade
Análise Multivariada
Razão de Chances
Prevalência
Estudos Prospectivos
Autorrelato
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170927
[Lr] Data última revisão:
170927
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170722
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0180997


  10 / 9638 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28726256
[Au] Autor:Fisher JD
[Ad] Endereço:Montefiore-Einstein, Arrhythmia Service, Bronx, NY.
[Ti] Título:Injectable loop recorder (ILR): How to, where to, who to.
[So] Source:Pacing Clin Electrophysiol;40(9):981, 2017 09.
[Is] ISSN:1540-8159
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Eletrocardiografia Ambulatorial
Síncope
[Pt] Tipo de publicação:EDITORIAL; COMMENT
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171023
[Lr] Data última revisão:
171023
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170721
[St] Status:MEDLINE
[do] DOI:10.1111/pace.13148



página 1 de 964 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde